Your trusted market research partner
India is home to one of the largest diabetic patients in the world. In 2020, the total number of diabetic patients is around 77 million. Changed food behaviour and sedentary lifestyle in Indian metros are resulting in increased diabetic cases in the country. In the past 10 years, cases of diabetes have increased by a CAGR of 4.4% in the country.
At present, the aggregate size of the diabetic treatment market in India is valued at USD 8.1 Billion, which includes the cost of medicine, consultation, and lab test. Out of this, the size of the medicine is around 43% amounting to USD 3.48 billion. Consultation and lab testing constitutes 31% and 26% respectively.
Amongst treatment, 52.8% of Indians prefer oral drugs, whereas 14.2% of Indians undertake insulin. 23.9% of Indians prefer a combination of insulin and oral medicines. The remaining prefer other alternative forms of medication such as homeopathy and Ayurveda.
Indian diabetes care market is highly varied across India. The average per capita cost of treatment is relatively cheaper in the South and Eastern parts of India. In South India, the average cost of per capita treatment is 44% lesser than in North India. Similarly, the average cost of treatment is dearer in urban India as compared to rural parts of India. The Average Cost of treatment in urban India is 51.1% more as compared to rural India.